Skip to main content
$5.29 $0.13 (2.5%)

04:00 PM EDT on 07/28/21

ProQR Therapeutics (NASDAQ:PRQR)

CAPS Rating: No stars

Current Price $5.29 Mkt Cap $341.2M
Open $5.22 P/E Ratio 0.00
Prev. Close $5.29 Div. (Yield) $0.00 (0.0%)
Daily Range $5.11 - $5.32 Volume 135,113
52-Wk Range $3.40 - $9.46 Avg. Daily Vol. 427,853

Caps

How do you think NASDAQ:PRQR will perform against the market?

Add Stock to CAPS Watchlist

All Players

10 Outperform
2 Underperform
 

All-Star Players

3 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:PRQR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Bigsef77 (70.92)
Submitted September 05, 2018

ProQR's stock rockets to pace all gainers after upbeat drug trial results,MarketWatch•September 5, 2018Shares of ProQR Therapeutics NV (prqr) rocketed 66% to a near 3-year high in active morning trade Wednesday, to pace gainers on all the major… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:PRQR VS S&P 500 (SPY)

NASDAQ:PRQR Summary

Fools bullish on NASDAQ:PRQR are also bullish on:

Fools bearish on NASDAQ:PRQR are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PRQR.

Recs

2
Member Avatar Bigsef77 (70.92) Submitted: 9/5/2018 10:37:52 AM : Outperform Start Price: $3.05 NASDAQ:PRQR Score: +18.85

ProQR's stock rockets to pace all gainers after upbeat drug trial results
,MarketWatch•September 5, 2018

Shares of ProQR Therapeutics NV (prqr) rocketed 66% to a near 3-year high in active morning trade Wednesday, to pace gainers on all the major exchanges, after the company said results from a phase 1/2 trial for the treatment of Leber's congenital amaurosis, a cause for blindness in children, warranted the progression to a phase 2/3 trial. The company said in the trial, QR-110 demonstrated "meaningful improvement" in vision, as early as two months after treatment and was stable by three months.

Leaderboard

Find the members with the highest scoring picks in PRQR.

Score Leader

DavidSobel

DavidSobel (< 20) Score: +131.58

The Score Leader is the player with the highest score across all their picks in PRQR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
yosemitebean 37.02 9/6/2018 Underperform 5Y $16.40 -67.74% +51.77% +119.51 0 Comment
anchak 54.95 9/6/2018 Underperform NS $16.40 -67.74% +51.77% +119.51 0 Comment
Bigsef77 70.92 1/25/2018 4/5/2021 Outperform 3Y $3.05 +73.44% +54.59% +18.85 1 Comment
portefeuille3 95.77 12/27/2017 Outperform 5Y $3.04 +74.01% +64.08% +9.94 0 Comment
kfassini < 20 2/26/2021 Outperform 5Y $4.39 +20.50% +15.19% +5.31 0 Comment
drugtrader 86.69 12/14/2020 Outperform 5Y $4.35 +21.61% +19.66% +1.95 0 Comment
TruffelPig < 20 5/18/2021 Outperform 5Y $6.51 -18.74% +5.54% -24.28 0 Comment
stainsolution 68.30 2/10/2017 Outperform 5Y $4.20 +25.95% +89.57% -63.62 0 Comment
beecha 68.61 9/19/2017 Outperform 5Y $6.25 -15.36% +75.53% -90.89 0 Comment
dollarsandcents1 < 20 2/11/2016 Outperform 5Y $3.90 +35.64% +138.93% -103.29 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PRQR.